DEPOMED INC's ticker is DEPO and the CUSIP is 249908104. A total of 210 filers reported holding DEPOMED INC in Q4 2015. The put-call ratio across all filers is 0.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $81,000 | -2.4% | 12,128 | -3.4% | 0.00% | 0.0% |
| Q1 2018 | $83,000 | -46.5% | 12,557 | -34.7% | 0.00% | 0.0% |
| Q4 2017 | $155,000 | -6.6% | 19,231 | +126.7% | 0.00% | 0.0% |
| Q2 2016 | $166,000 | +59.6% | 8,482 | +13.7% | 0.00% | 0.0% |
| Q1 2016 | $104,000 | +4.0% | 7,458 | +35.1% | 0.00% | 0.0% |
| Q4 2015 | $100,000 | -27.5% | 5,521 | -24.9% | 0.00% | 0.0% |
| Q3 2015 | $138,000 | +181.6% | 7,347 | +222.2% | 0.00% | – |
| Q2 2015 | $49,000 | +22.5% | 2,280 | +28.1% | 0.00% | – |
| Q1 2015 | $40,000 | +42.9% | 1,780 | +1.9% | 0.00% | – |
| Q4 2014 | $28,000 | -9.7% | 1,747 | -15.0% | 0.00% | – |
| Q3 2014 | $31,000 | +3.3% | 2,055 | -6.0% | 0.00% | – |
| Q2 2014 | $30,000 | -6.2% | 2,186 | 0.0% | 0.00% | – |
| Q1 2014 | $32,000 | +45.5% | 2,186 | +3.2% | 0.00% | – |
| Q4 2013 | $22,000 | -59.3% | 2,119 | -70.5% | 0.00% | – |
| Q3 2013 | $54,000 | +145.5% | 7,189 | +86.9% | 0.00% | – |
| Q2 2013 | $22,000 | – | 3,846 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DELTEC ASSET MANAGEMENT LLC | 2,252,402 | $31,376,000 | 7.88% |
| Healthcare Value Capital, LLC | 350,000 | $4,876,000 | 7.16% |
| Senvest Management, LLC | 4,977,256 | $69,333,000 | 5.82% |
| Consonance Capital Management LP | 2,756,360 | $38,396,000 | 5.81% |
| Opaleye Management Inc. | 325,000 | $4,527,000 | 2.82% |
| Krensavage Asset Management, LLC | 447,000 | $6,227,000 | 2.23% |
| Healthcare Value Capital, LLC | 100,000 | $1,393,000 | 2.05% |
| Starboard Value LP | 2,950,000 | $41,094,000 | 1.44% |
| HealthInvest Partners AB | 200,000 | $2,786,000 | 1.30% |
| OAK RIDGE INVESTMENTS LLC | 7,206,286 | $100,384,000 | 1.29% |